Venus Remedies bags second PLI disbursement for FY25, nears full-year incentive
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Hongene will focus on developing and scaling production of key capping reagents—essential components of mRNA therapeutics—emphasizing accessibility, transparency, and global deployment
This license is a key regulatory milestone in advancing Hester's prevention-led poultry healthcare portfolio
The product delivers 100 percent of the Recommended Dietary Allowance (RDA) of three essential nutrients—Biotin, Vitamin C and Zinc
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
The RMAT designation accelerates the development of regenerative medicine therapies for serious or life-threatening diseases
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
Subscribe To Our Newsletter & Stay Updated